![David Montecalvo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Montecalvo
Directeur/Membre du Conseil chez
Olin Business School
Profil
David A. Montecalvo est SVP, Chief Operations & Supply Chain Officer chez West Pharmaceutical Services, Inc. Dans le passé, il a occupé le poste de vice-président des opérations chez Urologix, Inc. et de vice-président des opérations de fabrication sous contrat chez Medtronic Plc et de vice-président du développement des produits et des opérations chez Medtronic CardioVascular (une filiale de Medtronic Plc). Il a obtenu un MBA de l'université St. Thomas (Floride) et un diplôme de premier cycle de l'université Case Western Reserve.
Postes actifs de David Montecalvo
| Sociétés | Poste | Début |
|---|---|---|
Olin Business School
 Olin Business School Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 01/02/2017 |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Consultant / Advisor | 01/10/2022 |
Vance Street Management LLC
 Vance Street Management LLC Investment ManagersFinance Vance Street invests in middle market companies located in the United States or Canada with an enterprise values of USD 30 - 350 million and EBITDA of USD 3 - 30 million. The firm focuses on medical, industrial technology, life science, aerospace and defense. It provides financing for management buyouts, recapitalizations of family businesses, corporate carve-outs, add on acquisitions, industry consolidations and growth capital requirements. | Private Equity Investor | 01/09/2024 |
Anciens postes connus de David Montecalvo
| Sociétés | Poste | Fin |
|---|---|---|
Sterlingtech, Inc.
 Sterlingtech, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices | Directeur Général | 01/11/2023 |
| WEST PHARMACEUTICAL SERVICES, INC. | Directeur des opérations | 12/05/2022 |
RBC Development LLC
 RBC Development LLC Packaged SoftwareTechnology Services Develops designs and manufacturing services for medical technology company | Directeur Général | - |
Medtronic CardioVascular
 Medtronic CardioVascular Medical SpecialtiesHealth Technology Manufactures medical devices | Directeur des opérations | - |
| MEDTRONIC PLC | Corporate Officer/Principal | - |
Formation de David Montecalvo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
34
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Urologix, Inc.
 Urologix, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets minimally invasive urological treatment products | Health Technology |
West Pharmaceutical Services, Inc.
 West Pharmaceutical Services, Inc. Medical SpecialtiesHealth Technology Manufactures and markets pharmaceuticals, biologics, vaccines & consumer healthcare products | Health Technology |
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Thomas University (Florida)
 St. Thomas University (Florida) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic CardioVascular
Medtronic CardioVascular Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Vance Street Management LLC
Vance Street Management LLC Investment ManagersFinance Vance Street invests in middle market companies located in the United States or Canada with an enterprise values of USD 30 - 350 million and EBITDA of USD 3 - 30 million. The firm focuses on medical, industrial technology, life science, aerospace and defense. It provides financing for management buyouts, recapitalizations of family businesses, corporate carve-outs, add on acquisitions, industry consolidations and growth capital requirements. | Finance |
Olin Business School
Olin Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Plc
 Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
Sterlingtech, Inc.
Sterlingtech, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
RBC Development LLC
RBC Development LLC Packaged SoftwareTechnology Services Develops designs and manufacturing services for medical technology company | Technology Services |
Choisissez Zonebourse 
